Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?

11 Apr 2006

Abstract excerpt

PURPOSE OF REVIEW: This review summarizes current knowledge on asymmetric dimethylarginine, renal function in health and disease, and renal disease progression and examines interventions that may modify the plasma concentration of this methylarginine. RECENT FINDINGS: Nitric oxide deficiency may occur in patients with chronic kidney disease and may contribute to accelerate progression of chronic kidney disease,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Research and Treatment
Share to Cardiovascular Issues in Pregnancy
Share to Nitric Oxide and Endothelin Effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16609301
DOI: 10.1097/01.mnh.0000222701.22583.e8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?PMID 16609301Read ↗

Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiencySemantic proximity Read ↗

Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphisms.Semantic proximity Read ↗

Integrated genomics and metabolomics in nephrologySemantic proximity Read ↗

The role of DDAH and ADMA in kidney diseaseSemantic proximity Read ↗

Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.Semantic proximity Read ↗

Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.Semantic proximity Read ↗

ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.Semantic proximity Read ↗

Effect of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine on ischemic heart disease risk: A Mendelian randomization study.Semantic proximity Read ↗

Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.Semantic proximity Read ↗

Renalase in hypertension and kidney disease.Semantic proximity Read ↗

The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.Semantic proximity Read ↗

Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.